This phase 3 trial tests whether transplanting insulin-producing cells (islets) from donors can improve blood sugar control in 21 adults with type 1 diabetes who still experience dangerous low blood sugar episodes despite intensive insulin therapy. Participants receive the islet …
Phase: PHASE3 • Sponsor: CellTrans Inc. • Aim: Disease control
Last updated May 06, 2026 13:38 UTC